51 studies found for:    "autosomal recessive cerebellar ataxia type 1" OR "Cerebellar Ataxia"
Show Display Options
Rank Status Study
21 Completed Coenzyme Q10 in Adult-Onset Ataxia
Condition: Sporadic Ataxia
Interventions: Drug: Placebo (sugar pill);   Drug: Coenzyme Q10
22 Completed A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Condition: Spinocerebellar Degeneration
Interventions: Drug: KPS-0373;   Drug: Placebo
23 Unknown  Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)
Conditions: Ataxia Telangiectasia;   Growth Failure
Intervention: Drug: Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate
24 Recruiting A Long-Term Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Condition: Spinocerebellar Degeneration
Interventions: Drug: KPS-0373, High dose;   Drug: KPS-0373, Low dose
25 Unknown  Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations
Conditions: Spinocerebellar Ataxias;   Spastic Paraplegias
Intervention:
26 Completed The Effect of Whole Body Vibration Training on Neuromuscular Property in Individuals With Ataxia
Condition: Spinocerebellar Ataxia
Intervention: Other: Whole body vibration training
27 Active, not recruiting Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND)
Conditions: Spinocerebellar Ataxia - All Sub-types;   Friedreich's Ataxia
Intervention: Other: Ataxia rating scale
28 Completed Safety and Tolerability of Lithium in Spinocerebellar Ataxia 2 (SCA2)
Condition: SPINOCEREBELLAR ATAXIA 2
Intervention: Drug: LITHIUM CARBONATE
29 Completed A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Condition: SCD
Interventions: Drug: KPS-0373;   Drug: Placebo
30 Recruiting A 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Condition: Spinocerebellar Degeneration
Interventions: Drug: KPS-0373, High dose;   Drug: KPS-0373, Low dose
31 Completed Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Condition: Spinocerebellar Degeneration
Intervention: Drug: KPS-0373
32 Unknown  Immunogenicity of Pneumococcal Vaccines in Ataxia-telangiectasia Patients
Condition: Ataxia Telangiectasia
Interventions: Biological: Prevenar® (7-valent pneumococcal conjugate vaccine);   Biological: Pneumovax® (pneumococcal polysaccharide vaccine)
33 Completed Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia
Condition: Spinocerebellar Ataxia
Intervention: Biological: IVIG
34 Completed Lithium Treatment for Patients With Spinocerebellar Ataxia Type I
Condition: Spinocerebellar Ataxia Type I
Intervention: Drug: Lithium Carbonate
35 Recruiting International Ataxia Rating Scale in Younger Patients
Condition: Ataxia Telangiectasia
Intervention:
36 Completed Measuring Neurological Impairment and Functional Visual Assessment In Spinocerebellar Ataxias
Condition: Spinocerebellar Ataxia
Intervention:
37 Completed Study for Treatment of Cancer in Children With Ataxia-telangiectasia
Condition: Ataxia-Telangiectasia
Interventions: Drug: vinblastine, vincristine, prednisone, daunorubicin;   Drug: doxorubicin, methotrexate, cyclophosphamide, L-asparaginase;   Drug: etoposide, cytarabine, mercaptopurine;   Drug: dexamethasone, procarbazine;   Procedure: chemotherapy, intrathecal chemotherapy, steroid therapy
38 Completed The Investigation of the Pre-movement Facilitation of Agonist-antagonist Muscles and the Effect of the Feedforward Rehabilitation in Individuals With Hypermetria
Condition: Spinocerebellar Atrophy (SCA)
Intervention: Other: Temporal electrical stimulation
39 Completed Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3
Condition: Spinocerebellar Ataxia Type 3
Interventions: Drug: varenicline;   Drug: placebo
40 Recruiting Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
Conditions: Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 6
Intervention: Genetic: All Participants

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-51) Show next page of results
Indicates status has not been verified in more than two years